| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM199111143252006 |
| P698 | PubMed publication ID | 1656260 |
| P2093 | author name string | Burke A | |
| Wasserman GM | |||
| Echeverria P | |||
| Merrell BR | |||
| Green KY | |||
| Hyams KC | |||
| Bourgeois AL | |||
| Escamilla J | |||
| Thornton SA | |||
| Rozmajzl P | |||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1423-1428 | |
| P577 | publication date | 1991-11-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Diarrheal disease during Operation Desert Shield | |
| P478 | volume | 325 |
| Q41083618 | A cross-sectional analysis of clinical presentations of and risk factors for enteric protozoan Infections in an Active Duty Population during Operation Iraqi Freedom |
| Q60530748 | A food-borne outbreak of Shigella sonnei gastroenteritis, Austria, 2008 |
| Q43176794 | Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results |
| Q41931437 | Acute diarrhea during army field exercise in southern China. |
| Q72923492 | Acute infectious diarrhea |
| Q38301031 | An analysis of the medical problems of the Civil War |
| Q34046378 | Ancestral lineages of human enterotoxigenic Escherichia coli |
| Q34991203 | Antimicrobial resistance and genetic diversity of Shigella sonnei isolates from western Ireland, an area of low incidence of infection |
| Q48585808 | Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-ind |
| Q39519924 | Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection |
| Q33597022 | Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli |
| Q37083529 | Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East. |
| Q36844719 | Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road |
| Q36862603 | Coli surface antigens associated with enterotoxigenic Escherichia coli strains isolated from persons with traveler's diarrhea in Asia. |
| Q61806436 | Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS) |
| Q39463126 | Combat-training increases intestinal permeability, immune activation and gastrointestinal symptoms in soldiers |
| Q34194587 | Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers |
| Q37132203 | Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations |
| Q36101210 | Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries |
| Q39573053 | Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model |
| Q84935450 | Deployment-associated functional gastrointestinal disorders: do we know the etiology? |
| Q44723508 | Development of a travelers' diarrhea vaccine for the military: how much is an ounce of prevention really worth? |
| Q36539943 | Diagnostic approach to acute diarrheal illness in a military population on training exercises in Thailand, a region of campylobacter hyperendemicity |
| Q40192789 | Diarrhea in U.S. troops deployed to Thailand. |
| Q34344854 | Diarrhea outbreak during U.S. military training in El Salvador |
| Q58108357 | Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome |
| Q33877398 | Dr. Kiyoshi Shiga: discoverer of the dysentery bacillus |
| Q34645383 | Endemic infectious diseases of Afghanistan |
| Q33841513 | Enteric disease surveillance under the AFHSC-GEIS: current efforts, landscape analysis and vision forward. |
| Q24530558 | Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention |
| Q40490533 | Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells |
| Q40734581 | Epidemiology and clinical aspects of imported tropical diseases |
| Q34464976 | Epidemiology of traveler's diarrhea |
| Q52640720 | Evidence for Somatic Hypersensitivity in Veterans with Gulf War Illness and Gastrointestinal Symptoms. |
| Q39108374 | Food-borne outbreak of gastroenteritis associated with genogroup I calicivirus |
| Q36006695 | Gastroenteritis outbreak in British troops, Iraq |
| Q26782590 | Gastrointestinal Infections in Deployed Forces in the Middle East Theater: An Historical 60 Year Perspective |
| Q35987020 | Gastrointestinal problems in modern wars: clinical features and possible mechanisms |
| Q34716080 | Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain |
| Q36172686 | Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation. |
| Q35038311 | Healthcare utilization and mortality among veterans of the Gulf War. |
| Q30419963 | Hotel clinic-based diarrheal and respiratory disease surveillance in U.S. service members participating in Operation Bright Star in Egypt, 2009 |
| Q34004347 | Identification of a gene within a pathogenicity island of enterotoxigenic Escherichia coli H10407 required for maximal secretion of the heat-labile enterotoxin. |
| Q36545068 | Identification of enteroinvasive Escherichia coli and Shigella strains in pediatric patients by an IpaC-specific enzyme-linked immunosorbent assay |
| Q35521181 | Immune response to Shigella sonnei in U.S. Marines |
| Q35689012 | Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli |
| Q64449454 | Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains |
| Q46307485 | Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model |
| Q34334112 | Importance of heat-labile enterotoxin in colonization of the adult mouse small intestine by human enterotoxigenic Escherichia coli strains |
| Q35815599 | In vitro activity of azithromycin against bacterial enteric pathogens |
| Q36015835 | Incidence, Etiology and Risk Factors for Travelers' Diarrhea during a Hospital Ship-Based Military Humanitarian Mission: Continuing Promise 2011. |
| Q40842283 | Infectious diarrhoea. Viruses |
| Q33757644 | Intracellular activity of azithromycin against bacterial enteric pathogens |
| Q57661861 | Introduction: Human Enteric Caliciviruses—An Emerging Pathogen Whose Time Has Come |
| Q43082734 | Isolation of enterotoxigenic Escherichia coli from British troops in Saudi Arabia |
| Q92350211 | Magnitude, distribution, risk factors and care-seeking behaviour of acute, self-reported gastrointestinal illness among US Army Soldiers: 2015 |
| Q39446480 | Management of travellers' diarrhoea |
| Q35499729 | Molecular characterization of the tia invasion locus from enterotoxigenic Escherichia coli |
| Q54525383 | Murine antibody response to intranasally administered enterotoxigenic Escherichia coli colonization factor CS6 |
| Q40765845 | Norwalk-like virus infection in military forces: epidemic potential, sporadic disease, and the future direction of prevention and control efforts |
| Q78115914 | Novel self-sampling culture method to monitor excretion of live, oral Shigella flexneri 2a vaccine SC602 during a community-based phase 1 trial |
| Q46564196 | Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen |
| Q79612647 | Past trends and current status of self-reported incidence and impact of disease and nonbattle injury in military operations in Southwest Asia and the Middle East |
| Q54631164 | Positive correlation between the age of patients and the degree of antimicrobial resistance among urinary strains of Escherichia coli. |
| Q37105553 | Progress and pitfalls in Shigella vaccine research |
| Q73507076 | Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition |
| Q40489376 | Quinolones in the Treatment of Acute Bacterial Diarrhoeal Diseases |
| Q72866239 | Randomised trial of single-dose ciprofloxacin for travellers' diarrhoea |
| Q36844890 | Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G. |
| Q42227472 | Recent trends in the epidemiology of shigellosis in Israel |
| Q43522303 | Risk of functional gastrointestinal disorders in U.S. military following self-reported diarrhea and vomiting during deployment |
| Q40939738 | Role of quinolones in the treatment of diarrhoeal diseases |
| Q34120919 | Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously |
| Q34007642 | Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adults |
| Q33767325 | Salmonella and Shigella species. |
| Q43676688 | Sensitivity of acid-adapted and acid-shocked Shigella flexneri to reduced pH achieved with acetic, lactic, and propionic acids |
| Q34202171 | Shigella isolates from the global enteric multicenter study inform vaccine development |
| Q56383780 | Shigellosis |
| Q37248171 | Specific detection of Campylobacter jejuni and Campylobacter coli by using polymerase chain reaction |
| Q36593894 | The EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection |
| Q54473807 | The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine. |
| Q36167359 | The burden of different pathogens in acute diarrhoeal episodes among a cohort of Egyptian children less than five years old |
| Q33914442 | The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. |
| Q30597282 | The extant World War 1 dysentery bacillus NCTC1: a genomic analysis |
| Q39534347 | The impact of post-infectious functional gastrointestinal disorders and symptoms on the health-related quality of life of US military personnel returning from deployment to the Middle East |
| Q34048353 | The pCoo plasmid of enterotoxigenic Escherichia coli is a mosaic cointegrate |
| Q39414664 | Three-year prevalence of enteropathogenic bacteria in an urban patient population in Germany |
| Q39503687 | Travel to the Persian Gulf. Medical guidelines for visitors |
| Q35398962 | Travelers' diarrhea. Prevention and treatment |
| Q61448554 | Travelers' diarrhea: update on the incidence, etiology and risk in military and similar populations - 1990-2005 versus 2005-2015, does a decade make a difference? |
| Q26799737 | Tropical and travel-associated norovirus: current concepts |
| Q35073470 | Use of pulsed-field gel electrophoresis for comparison of similar but distinguishable isolates of Shigella sonnei collected in Ireland and Italy |
| Q33578045 | Vaccines against human diarrheal pathogens: current status and perspectives |
Search more.